Standout Papers

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial 2023 2026 2024100
  1. Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (2023)
    Ingo K. Mellinghoff, Min Lu et al. Nature Medicine

Immediate Impact

3 by Nobel laureates 48 from Science/Nature 63 standout
Sub-graph 1 of 23

Citing Papers

Primary brain tumours in adults
2023 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
1 intermediate paper

Works of Sung Choe being referenced

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
2023 Standout
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
2016

Author Peers

Author Last Decade Papers Cites
Sung Choe 1068 107 340 230 48 1.7k
Osnat Ashur‐Fabian 705 109 242 309 59 1.6k
Nagi G. Ayad 1711 141 316 421 57 2.1k
Noël Lamandé 857 33 289 122 38 1.6k
Adriana Aguilar‐Mahecha 811 55 617 413 40 1.6k
Dorina Gui 848 235 240 335 50 1.7k
Francesc Alameda 767 37 323 363 78 1.7k
Saya Ito 1337 91 155 209 62 1.9k
Daniela Meco 557 75 246 350 42 1.5k
Susanne N. Weber 1047 75 216 203 66 1.9k
Carsten Hagemann 1107 56 414 398 73 2.0k

All Works

Loading papers...

Rankless by CCL
2026